Print

V520-027

Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)

Trial Details:

II Terminated
Merck October 01, 2006
MRKAd5 HIV-1 gag/pol/nef Ad5 Gag,pol,nef
MRKAd5 HIV-1 gag/pol/nef Viral Vector - Adeno
MRKAd5 HIV-1 gag/pol/nef Viral Vector - Adeno
MRKAd5 HIV-1 gag/pol/nef Viral Vector - Adeno
USA
NCT00350623
http://clinicaltrials.gov/ct2/show/NCT00350623